中文名称: | 盐酸哌唑嗪 促销 | ||||
---|---|---|---|---|---|
英文名称: | Prazosin hydrochloride | ||||
别名: | 盐酸哌唑嗪 Prazosin hydrochloride | ||||
CAS No: | 19237-84-4 | 分子式: | C19H21N5O4.HCl | 分子量: | 419.86 |
CAS No: | 19237-84-4 | ||||
分子式: | C19H21N5O4.HCl | ||||
分子量: | 419.86 | ||||
MDL: | MFCD00058177 | EINEC: | 242-903-4 | ||
EINEC: | 242-903-4 |
基本信息
产品编号: |
P10869 |
||||
产品名称: |
Prazosin hydrochloride |
||||
CAS: |
19237-84-4 |
储存条件 |
粉末 |
2-8℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
419.86 |
-20℃ |
1个月 |
||
化学名: |
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine hydrochloride |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
1mg/mL warmed with 50ºC water bath (2.38mM) |
|||
Ethanol |
Insoluble |
||||
Water |
Insoluble |
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.3817mL |
11.9087mL |
23.8175mL |
5mM |
0.4763mL |
2.3817mL |
4.7635mL |
10mM |
0.2382mL |
1.1909mL |
2.3817mL |
生物活性
产品描述 |
一种α 肾上腺素阻断剂,可作用于高血压、焦虑和恐慌症等。 |
||
靶点 |
Adrenergic Receptor |
Autophagy |
|
体外研究 |
Prazosin (0,2.5,5,7.5,10,15,20,30,40 and 50µM) effectively inhibits the proliferation of U251 and U87 cells.Prazosin inhibits the migration and invasion of U251 and U87 cells.Prazosin treatment decreases the protein expression of components of the PI3K/AKT/mTOR signaling pathway.Prazosin (13.16 and 11.57µM for U251 and U87 cells,48 hours) decreases the expression levels of P70 and cyclin D1,which are downstream target genes of the PI3K/AKT/mTOR signaling pathway. Cell Proliferation Assay |
||
Cell Line: |
U251 and U87 cells |
||
Concentration: |
0,2.5,5,7.5,10,15,20,30,40 and 50µM. |
||
Incubation Time: |
48 hours |
||
Result: |
The IC50s were 13.16±0.95 and 11.57±0.79µM for U251 and U87 cells,respectively. |
||
Western Blot Analysis |
|||
Cell Line: |
U251 and U87 cells |
||
Concentration: |
13.16 and 11.57µM for U251 and U87 cells,respectively |
||
Incubation Time: |
48 hours |
||
Result: |
Protein expression levels of Bax and active Caspase-3 were increased.Bcl-2 levels were also decreased after prazosin treatment (P<0.05).The expression of p-AKT and p-mTOR,P70 and cyclin D1 were decreased. |
||
体内研究 |
Peripheral administration of Prazosin (0,0.5,1.0,1.5 or2.0mg/kg;i.p.) can suppress not only centralα1-adrenergicmediated hyperexcitability but also stress-induced anxiety. |
||
Animal Model: |
Fifty-five alcohol-naive male rats from the 60th generation of selective breeding for alcohol preference |
||
Dosage: |
0.5,1.0,1.5,or 2.0mg/kg |
||
Administration: |
Injected intraperitoneally (IP);0.5mg/mL;once a day at 15 min prior to onset of the daily two hour two-bottle choice,alcohol versus water,access period for two consecutive days and then three weeks later for five consecutive days. |
||
Result: |
Significantly reduced alcohol intake during the initial two daily administrations,and this reduction of alcohol intake was maintained for five consecutive days by daily prazosin treatment in the subsequent more prolonged trial. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )